-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Sialon Pharmaceutical announced that the company's wholly-owned subsidiary Hunan Sailon Pharmaceutical's tigecycline for injection and thymosin for injection passed the consistency evaluation
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
Tigecycline, a glycylcycline anti-infective drug, is clinically used for complex intra-abdominal infections, complex skin and skin and soft tissue infections, and community-acquired bacterial pneumonia caused by sensitive strains of specific bacteria
.
.
There are 11 domestic pharmaceutical companies that have approval for the production of tigecycline for injection.
According to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
According to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
Application of Consistency Evaluation of Tigecycline for Injection
Source: Minet Consistency Evaluation Database
Tigecycline for injection is planned to be included in the seventh batch of centralized procurement.
At present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
At present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
According to the data from Minet.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
Sialon Pharmaceutical's over-evaluation
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition to tigecycline for injection, milrinone injection and omeprazole sodium for injection are also planned to be included in the seventh batch of centralized procurement.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
Source: Mi Intranet database, announcements of listed companies, etc.
A few days ago, Sialon Pharmaceutical announced that the company's wholly-owned subsidiary Hunan Sailon Pharmaceutical's tigecycline for injection and thymosin for injection passed the consistency evaluation
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
Tigecycline, a glycylcycline anti-infective drug, is clinically used for complex intra-abdominal infections, complex skin and skin and soft tissue infections, and community-acquired bacterial pneumonia caused by sensitive strains of specific bacteria
.
.
There are 11 domestic pharmaceutical companies that have approval for the production of tigecycline for injection.
According to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
According to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
Application of Consistency Evaluation of Tigecycline for Injection
Source: Minet Consistency Evaluation Database
Tigecycline for injection is planned to be included in the seventh batch of centralized procurement.
At present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
At present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
According to the data from Minet.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
Sialon Pharmaceutical's over-evaluation
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition to tigecycline for injection, milrinone injection and omeprazole sodium for injection are also planned to be included in the seventh batch of centralized procurement.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
Source: Mi Intranet database, announcements of listed companies, etc.
A few days ago, Sialon Pharmaceutical announced that the company's wholly-owned subsidiary Hunan Sailon Pharmaceutical's tigecycline for injection and thymosin for injection passed the consistency evaluation
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
.
According to data from Minet.
com, the sales volume of these two injections in public medical institutions in China will exceed 2 billion yuan in 2020
.
Tigecycline, a glycylcycline anti-infective drug, is clinically used for complex intra-abdominal infections, complex skin and skin and soft tissue infections, and community-acquired bacterial pneumonia caused by sensitive strains of specific bacteria
.
.
There are 11 domestic pharmaceutical companies that have approval for the production of tigecycline for injection.
According to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
hospital hospital hospitalAccording to Minet.
com, the product will be used in urban public hospitals , county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) in 2020.
Terminal sales are close to 2.
5 billion yuan, a year-on-year increase of 6.
42% in the first half of 2021
.
Judging from the competition pattern of manufacturers, Hansoh, Pfizer and Chia Tai Tianqing rank among the top three
.
Application of Consistency Evaluation of Tigecycline for Injection
Source: Minet Consistency Evaluation Database
Tigecycline for injection is planned to be included in the seventh batch of centralized procurement.
At present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
enterprise enterprise enterpriseAt present, including Sialon Pharmaceuticals, the products of 9 companies have passed or are deemed to have passed the consistency evaluation and obtained admission tickets for centralized procurement
.
According to the data from Minet.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
com, there are currently 8 varieties of Sialon Pharmaceuticals that have passed or are deemed to have passed the consistency evaluation, all of which are injections, of which 3 are digestive system and metabolic drugs
.
Sialon Pharmaceutical's over-evaluation
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition to tigecycline for injection, milrinone injection and omeprazole sodium for injection are also planned to be included in the seventh batch of centralized procurement.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
The three injections are all the best-selling drugs in the terminals of public medical institutions in China.
market share is low
.
Source: Mi Intranet database, announcements of listed companies, etc.
